Black Diamond Therapeutics, Inc. (BDTX)

Last Closing Price: 3.10 (2026-04-23)

Weighted-Average Shares Outstanding (Diluted) (Annual)

Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.

Black Diamond Therapeutics, Inc. (BDTX) had Weighted-Average Shares Outstanding (Diluted) of 57.56M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$70.00M
$22.37M
--
$70.00M
$57.48M
$12.52M
$9.85M
$22.37M
$22.37M
$22.37M
$22.37M
$22.37M
$22.37M
$12.52M
$12.85M
56.87M
Weighted-Average Shares Outstanding (Diluted)
57.56M
$0.39
$0.39
Balance Sheet Financials
$132.44M
$0.36M
$10.57M
$143.01M
$15.73M
--
$15.07M
$30.80M
$112.21M
$112.21M
$112.21M
57.14M
Cash Flow Statement Financials
$29.61M
$-44.91M
$-0.15M
$37.26M
$21.82M
$-15.44M
$6.63M
--
--
Fundamental Metrics & Ratios
8.42
--
--
--
--
100.00%
17.89%
17.89%
18.35%
31.95%
31.95%
$29.64M
--
--
--
0.49
--
--
--
19.93%
19.93%
15.64%
19.93%
$1.96
$0.51
$0.51